Interim CEO tenures are stretching longer across hospital systems in 2026

Hospital and health system boards are leaving the top executive chair open longer in 2026, and the delay is measurable. In cases Becker’s has tracked this year where an interim CEO was eventually followed by a permanent appointment, the median time from the interim start date to the permanent announcement was 155 days, up from 127 days in comparable 2025 cases. The 2026 figure excludes seats still open, which means the true wait is already longer than the median suggests.

The numbers point to a slower decision cycle at a moment when hospitals are managing financial strain, workforce pressure and relentless operational complexity. In that environment, the CEO seat is not a ceremonial role. It determines capital allocation, labor strategy, service-line direction and the pace of systemwide restructuring.

Six systems have stayed with interim leadership for more than 140 days

Several organizations remain under interim leadership months after the transition began. As of Oct. 20, six health systems had been led by interim CEOs for more than 140 days without a permanent successor named: Lewiston-based Central Maine Healthcare, Ogdensburg, N.Y.-based North Star Health Alliance, Ascension Wisconsin in Glendale, Abilene, Texas-based Hendrick Health, Chesapeake, Va.-based Regional Healthcare and Rockville Centre, N.Y.-based Catholic Health on Long Island. The interim period began as early as Feb. 17 at Central Maine Healthcare and as late as June 2 at Catholic Health on Long Island.

A prolonged interim tenure can mean a board is still defining what it wants from the next leader, or that the system is weighing internal candidates against outside contenders with different operating philosophies. In a hospital setting, those differences are not abstract. A board leaning toward turnaround discipline may seek a leader with labor and balance-sheet expertise, while another may prioritize clinical integration, physician alignment or expansion.

The delay can also reflect a broader caution among boards that want the next appointment to endure. A permanent chief executive is expected to absorb strategic risk, not just keep the lights on.

Promoting the interim moved faster than bringing in an outside replacement

The fastest transitions tended to occur when the interim CEO was promoted into the permanent role. West Burlington, Iowa-based Great River Health filled the seat in 52 days, Hunterdon Health in Flemington, N.J., did so in 89 days, Mammoth Hospital in Mammoth Lakes, Calif., in 90 days, WVU Medicine St. Joseph’s in Buckhannon, W.Va., in 150 days and Maui Health in Wailuku, Hawaii, in 169 days.

By contrast, systems that chose a different leader generally took longer. Mercy Medical Center in Cedar Rapids, Iowa, needed 179 days, Kearney Regional Medical Center in Nebraska took 202 days and McLaren Port Huron in Michigan took 236 days. The pattern is unsurprising. An interim who already knows the operating culture, board expectations and internal friction points can move faster than an outside executive who must first build trust, map the organization and assess the inherited problems.

Speed, in this setting, often signals continuity. It can also reveal that a board has decided the interim already matches the institution’s strategic needs better than any external candidate on the field.

More interim leaders are staying on permanently

Becker’s has reported 18 interim-to-permanent CEO promotions in 2026 through Aug. 3, compared with 15 across all of 2025. The count suggests boards are not simply holding seats open indefinitely; they are still converting interim arrangements into lasting appointments at a steady pace. What has changed is the time it takes to get there.

One of the clearest examples came at Memorial Healthcare System in Hollywood, Fla., where Shane Strum had served in an interim capacity since 2024 before both hospital district boards voted Sept. 2 to make him permanent. Long interim service can give a board a live trial of leadership under pressure. It also gives the executive a chance to demonstrate whether he or she can manage governance demands, public scrutiny and operational stress without the insulation that comes with a full mandate.

Why the CEO vacancy matters inside hospitals

CEO turnover in hospitals carries consequences that extend beyond the executive suite. Leadership uncertainty can slow decisions on staffing, capital purchases, service consolidation and network partnerships. It can also affect physician confidence at a time when medical staff retention is already fragile in many markets. When the interim phase stretches across months, department leaders often end up waiting for clarity before committing to larger strategic changes.

There is also a signaling effect. Extended vacancy can suggest board caution, competing internal priorities or difficulty reaching consensus on the direction of the organization. In some systems, the pause may be intentional, allowing trustees to observe whether the interim can stabilize operations before making the role permanent. In others, the open seat may reflect a search process that is still searching for the right fit.

The clinical consequences are indirect but real. Hospitals function through coordination, and coordination depends on stable leadership. When the top role remains unsettled, operational drift can set in quietly, from delayed recruitment to postponed investments in throughput, safety infrastructure and payer negotiations.

A slower succession cycle points to tighter scrutiny at the board level

The current pattern does not point to one single explanation. Some boards may be moving more deliberately because the stakes have risen. Others may be encountering a thinner pool of candidates willing to take on distressed systems, multi-campus oversight or politically complex governance structures. A hospital CEO now inherits a balance sheet, a labor market and a public trust burden all at once.

What stands out in 2026 is not just the number of interim appointments, but the longer interval before permanence. The median wait has lengthened, several systems have remained in interim status for nearly half a year, and outside hires have generally taken the longest path to appointment.

The open question now is whether this slower cadence reflects stronger governance, deeper hesitation or both. The next round of CEO decisions will show whether boards are choosing patience as a management tool, or using interim leadership as a longer proving ground before committing to the next permanent chief executive.


Reporting by Dr. Clara Evans, DDS, MS, FACS for Medicine World Foundation, with additional data provided by Becker's Hospital Review.